N. Léone

Projection de l’incidence et de la mortalité par cancer urologique en France en 2012

J. Patard, L. Salomon, A. Villers, 2013 .

Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.

P. Arveux, A. Guizard, B. Trétarre, 2015, Gynecologic oncology.

Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study

C. Charpentier, Y. Yazdanpanah, D. Costagliola, 2022, BMC Infectious Diseases.

Focus on an unusual rise in pancreatic cancer incidence in France.

G. Launoy, V. Jooste, A. Bouvier, 2017, International journal of epidemiology.

[Prostate cancer incidence and mortality trends in France from 1980 to 2011].

P. Grosclaude, L. Remontet, M. Velten, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries.

M. Federico, E. Paci, A. Bordoni, 2013, Breast.

[Incidence and mortality of urological cancers in 2012 in France].

J. Patard, L. Salomon, A. Villers, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study

V. Zadnik, C. Castro, G. Tagliabue, 2020, Breast Cancer Research and Treatment.